Stephen Smith

25PUBLICATIONS
140CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunology not elsewhere classifiedPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Aug 14, 2026
Mosunetuzumab With Response-Adapted Polatuzumab Vedotin and Obinutuzumab in Untreated Indolent B-Cell Non-Hodgkin Lymphoma.

|Jul 17, 2026
Incidence and clinical impact of absolute lymphocyte count-only progression in chronic lymphocytic leukemia.

|Jun 17, 2026
Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.

|Jul 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

|Jun 17, 2025
Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.

Christina Poh, Jenna M Voutsinas, Mazyar Shadman

|Feb 12, 2025
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.

Laura Samples, Hossein Sadrzadeh, Matthew J Frigault

Pageof 5

Frequent Collaborators

10 joint publications

Mazyar Shadman

8 joint publications

Ajay K Gopal

8 joint publications

Ryan C Lynch

7 joint publications

Chaitra Ujjani